Riskpilot← Back to searchSign inGet full accessQUINTET AS
ASActiveOrg 928848752Øvre Kråkenes 17, 5152 BønesWholesale of pharmaceutical and medical goods · NACE 4646Est. 202215 employees
Revenue 2024
NOK 50,4M
+18% vs 2023
EBITDA margin
34.7%
+12% vs 2023
Equity ratio
37.9%
Financial strength
Net profit 2024
NOK 13,6M
+12% vs 2023
| Revenue | NOK 50,4M | +18% |
| EBITDA | NOK 17,5M | +12% |
| Net profit | NOK 13,6M | +12% |
| Total assets | NOK 30,8M | +13% |
| Equity | NOK 11,7M | +29% |
| Employees | 15 | — |
Legal name
QUINTET AS
Org number
928848752
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. mars 2022
Share capital
NOK 300 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Salg av medisinske hjelpemidler.
Address
Øvre Kråkenes 17, 5152 Bønes
Email
post@quintet.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 32 679 | 42 725 | 50 379 |
| Staff expenses | −6 905 | −7 515 | −8 137 |
| EBITDA | 11 544 | 15 542 | 17 474 |
| Depreciation & amort. | −122 | −0 | −51 |
| EBIT | 11 422 | 15 542 | 17 422 |
| Net financials | −2 | −8 | 74 |
| Profit before tax | 11 420 | 15 534 | 17 496 |
| Tax | 2 520 | 3 432 | 3 885 |
| Net profit | 8 900 | 12 102 | 13 611 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 19 514 | 27 359 | 30 842 |
| Equity | 6 986 | 9 088 | 11 699 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 12 528 | 18 271 | 19 142 |
| Total debt | 12 528 | 18 271 | 19 142 |
EBITDA margin
34.7%
This company
15.8%
Market median
+120% vs market
20222024
Equity ratio
37.9%
This company
38.2%
Market median
+1% vs market
20222024
Return on equity
116.3%
This company
18.4%
Market median
+532% vs market
20222024
Net profit margin
27.0%
This company
8.1%
Market median
+233% vs market
20222024
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20222024
Debt / equity
1.64×
This company
0.62×
Market median
-165% vs market
20222024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hanna Solberg As | Company | 83.3% | 83.3% | 2024 |
M. Bratt As | Company | 16.7% | 16.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hanna Solberg As
QUINTET AS Board members of QUINTET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Solberg | Chief Executive Officer | 0 companies |
| Sølvi Merethe Spilde Monsen | Chairman | 0 companies |
| Ingrid Borthen | Board of Directors | 0 companies |
| Anne Taule | Board of Directors | 0 companies |
| Per Olav Langaker | Board of Directors | 0 companies |
| Mads Søyland Bakjord | Board of Directors | 0 companies |
| Margrethe Bratt | Board of Directors | 0 companies |